Downloads: 1
| # | Blank 1 | Frequency | Blank 2 | Frequency | Blank 3 | Frequency | |
|---|---|---|---|---|---|---|---|
| 1 | 2 | patients with a | 14 | other than | 30 | skin cancers patients are not considered to have a currently active malignancy if they have completed therapy and are considered by their physician to be at less than 30 risk of relapse | 3 |
| 2 | 4 | 8 | except | 1 | skin cancers patients are not considered to have a currently active malignancy if they have completed therapy and are free of disease for > = 3 years | 2 | |
| 3 | 1 | subjects with a | 4 | other that | 1 | skin cancers non invasive bladder cancer low risk adenocarcinoma of the prostate and carcinoma in situ of the cervix patients are not considered to have a currently active malignancy if they have completed therapy and are free of disease for > = 2 years | 2 |
| 4 | 22 | patients may not have a | 2 | NA | skin cancers are not eligible | 2 | |
| 5 | 28 | any | 2 | NA | skin cancers | 2 | |
| 6 | 9 | second malignancy no | 1 | NA | skin cancers are not eligible patients are not considered to have a currently active malignancy if they have completed all therapy and are now considered without evidence of disease for 1 year | 2 | |
| 7 | 27 | no | 1 | NA | skin or superficial urothelial cancers are not eligible subjects are not considered to have a currently active malignancy if they have completed therapy and are now considered without evidence of disease for 2 years prior to cycle 1 day 1 | 1 | |
| 8 | 3 | NA | NA | skin cancers or non invasive bladder cancers or other in situ or non invasive malignancies . subjects are not considered to have a currently active malignancy if they have completed therapy and are free of disease for > = 3 years | 1 | ||
| 9 | 5 | NA | NA | skin cancer or carcinoma in situ of the cervix patients are not considered to have a currently active malignancy if they have completed therapy and have no evidence of recurrence for at least 5 years | 1 | ||
| 10 | 6 | NA | NA | skin cancers . | 1 | ||
| 11 | 7 | NA | NA | skin cancer | 1 | ||
| 12 | 8 | NA | NA | skin cancer or carcinoma in situ of the cervix . patients are not considered to have a currently active malignancy if they have completed therapy and have no evidence of recurrence for at least 5 years . | 1 | ||
| 13 | 10 | NA | NA | skin cancers non invasive bladder cancer low risk adenocarcinoma of the prostate and carcinoma in situ of the cervix patients are not considered to have a currently active malignancy if they have completed therapy and are free of disease for > = 3 years | 1 | ||
| 14 | 11 | NA | NA | skin cancers or non invasive bladder cancers or other in situ or non invasive malignancies patients who have completed therapy for a prior malignancy and are free of disease for > = 3 years are eligible | 1 | ||
| 15 | 12 | NA | NA | skin or superficial urothelial cancers are not eligible patients are not considered to have a currently active malignancy if they have completed therapy and are now considered without evidence of disease for 2 years | 1 | ||
| 16 | 13 | NA | NA | skin cancer . patients are not considered to have a currently active malignancy if they have completed necessary therapy and are considered by their physician to be at < 30 risk of relapse at time of assessment . | 1 | ||
| 17 | 14 | NA | NA | skin cancers or non muscle invasive transitional cell carcinoma of bladder patients are not considered to have a currently active malignancy if they have completed therapy and are now considered by their physician to be at less than 30 risk for relapse | 1 | ||
| 18 | 15 | NA | NA | skin cancers are not to be registered patients are not considered to have a currently active malignancy if they have completed therapy and considered by their physician to be at less than 30 risk of relapse | 1 | ||
| 19 | 16 | NA | NA | skin cancer or in situ carcinoma of the cervix or breast patients are not considered to have a currently active malignancy if they have completed anti cancer therapy are considered by their physician to be at less than 30 risk of relapse and at least 2 5 years have lapsed | 1 | ||
| 20 | 17 | NA | NA | skin cancers patients are not considered to have a currently active malignancy if they have completed therapy more than 3 years ago and are considered to have a less than 30 risk of relapse based on the enrolling investigator s assessment and documented in the medical record a history of prostate cancer that was identified incidentally following cystoprostatectomy or cystectomy for bladder cancer is acceptable provided that the following criteria are met r n stage t2n0m0 or lower r n gleason score = < 7 negative margins at surgery and prostate specific antigen psa undetectable after surgery | 1 | ||
| 21 | 18 | NA | NA | skin cancer . patients are not considered to have a currently active malignancy if they have completed therapy and are considered by their physician to be at least less than 30 risk of relapse over next 3 months . | 1 | ||
| 22 | 19 | NA | NA | skin cancers are not eligible patients are not considered to have a currently active malignancy if they have completed anti cancer therapy and are considered by their physician to be at less than 30 risk of relapse | 1 | ||
| 23 | 20 | NA | NA | skin cancer are excluded patients are not considered to have a currently active malignancy if they have completed therapy and are considered by their physician to be at less than 30 risk of relapse | 1 | ||
| 24 | 21 | NA | NA | skin cancer carcinoma in situ of the cervix or prostatic intraepithelial neoplasia within 1 year . subjects are not considered to have a currently active malignancy if they have completed therapy and are considered by their physician to be at less than 30 risk of relapse within 1 year . | 1 | ||
| 25 | 23 | NA | NA | skin cancer patients are not considered to have a currently active malignancy if they have completed therapy and are considered by their physician to be at least less than 30 risk of relapse over next year | 1 |